Faculty Biography
Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCPClinical Professor
University of Washington School of Pharmacy
Director, Anticoagulation Services
University of Washington Medical Center
Seattle, Washington
Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP, is Clinical Professor of Pharmacy at the University of Washington School of Pharmacy and Director of Anticoagulation Services at the University of Washington Medical Center. As a clinician and educator in the field of antithrombotic pharmacotherapy, she has contributed extensively to the care of patients and the education of health care providers regarding antithrombotic pharmacotherapy. She is the author of over 100 scientific papers, book chapters and abstracts, and co-editor of the textbook Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines. She has lectured widely throughout the United States and Canada, maintains an active clinical research program, and is board certified as an anticoagulation care provider.
Dr. Wittkowsky serves as an editorial board member for Pharmacotherapy and the Journal of Thrombosis and Thrombolysis, as a reviewer for numerous medical and scientific journals, and as a member of the board of directors of The Anticoagulation Forum, a multidisciplinary organization of anticoagulation care providers. She is the director of the Northwest Anticoagulation Consortium, a preceptor for the ASHP Research and Education Foundation’s Antithrombotic Pharmacotherapy Traineeship, a member of the American College of Chest Physicians’ 8th Conference on Antithrombotic and Thrombolytic Therapy, and was recently selected as a member of the 9th Conference. She is an elected member of the Board of Regents of the American College of Clinical Pharmacy.
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
The faculty and planners report the following relationships:
Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP, declares that she has served on the speakers bureau for sanofi-aventis.
Kristi N. Hofer, Pharm.D., declares that she has no relationships pertinent to this activity.